Oncovista Innovative Therapies Inc banner

Intrinsic Value

OVIT latest financial reports are more than 7 years old.
OVIT doesn't have a meaningful market cap.
Not Available for OVIT

There is not enough data to reliably calculate the intrinsic value for Oncovista Innovative Therapies Inc.

Do our valuations actually work? See backtest results .

Alternatives to OVIT

Fundamental Analysis

What Oncovista Innovative Therapies Does

Biotechnology Health Care

OncoVista Innovative Therapies, Inc. is a drug development company, which engages in the development and commercialization of targeted cancer therapies. The company is headquartered in San Antonio, Texas. The company went IPO on 2006-01-23. The firm is engaged in developing targeted anticancer therapies by utilizing tumor-associated biomarkers. The firm's product pipeline consists of advanced (Phase II) and early (Phase I) clinical-stage compounds, late preclinical drug candidates and early preclinical leads.

Headquarters
United States of America US
IPO date
Jan 23, 2006
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Oncovista Innovative Therapies Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape